In the headquarters of a mid-sized pharmaceutical company preparing for its first product launch, a scene once considered ...

Northway Biotech, a biopharmaceutical contract development and manufacturing organization (CDMO), today announced the ...

Korro Bio is laying off a fifth of its workforce as the Novo Nordisk-partnered biotech funnels resources to its ...

With long development timelines and high burn rates, biotech companies must navigate capital markets with precision.

I look forward to working with the team to reach new corporate and clinical milestones,” added Dieter Weinand, Chairman of ...

Avance Clinical, the award-winning, global CRO for biotechs, is proud to announce its sponsorship of the Citeline Awards 2025 ...

MassBio’s new report outlines several concerns, including NIH cuts undermining the research engine, FDA reductions delaying ...

As the largest funder of biomedical research in the world, the NIH is considered a global paragon. Budget cuts could lead to permanent cracks in the increasingly fragile research ecosystem, ...

In this way, these virtual biotechs are able to find a market for these compounds, since blockbusters and biosimilars are not as feasible for smaller biotech organizations. "The realities of the ...

Dr Matthias Magoola, the founder and managing director of Dei Biopharma Ltd, has been awarded one of the continent’s top ...

Story May 5 - Unity Biotechnology: Aging-focused Bay Area ... The CRISPR-focused company is working to ensure it has "the right organization to drive forward our internal programs to the clinic ...

By end use, the Contract Research Organizations (CROs) segment registered the maximum market share in 2024. By end use, the pharma & biotech organizations segment is predicted to grow with the ...